Open Government Portal

Canadian Sales of goods manufactured (shipments), new orders, unfilled orders, inventories, raw materials, goods or work in process, finished goods, and inventory to sales ratios for durable and non-durable goods by North American Industry Classification System (NAICS) for reference periods January 2002 to the current reference month. Not all combinations are available. Values are in constant dollars.

Historical monthly release of Canadian Sales of goods manufactured (shipments), new orders, unfilled orders, inventories, raw materials, goods or work in process, finished goods, and inventory to sales ratios for durable and non-durable goods by North American Industry Classification System (NAICS) for reference periods January 2002 to the current reference month. Not all combinations are available. Values are in constant dollars.

Historical monthly release of Canadian Sales of goods manufactured (shipments), new orders, unfilled orders, raw materials, goods or work in process, finished goods, total inventories, inventory to sales ratios and finished goods to sales ratios by North American Industry Classification System (NAICS), for reference periods January 2013 to the current reference month.

Medical devices that are eligible for importation and sale under the interim order (IO) are known as “designated” devices. They are included in the list of medical devices for exceptional importation and sale.

This document provides guidance to vaccine manufacturers seeking authorization for their vaccine that targets the SARS-CoV-2 virus. This guidance applies to applications under the interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19.

COVID-19 drugs must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with the international requirements outlined in the International Council for Harmonization Q7A guideline and with applicable Health Canada's guidance.

Good manufacturing practices (GMP) ensure that drugs meet the quality standards appropriate to their intended use before they are sold.

COVID-19 vaccines must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with international requirements, which are outlined in the International Council for Harmonization Q7A guideline and applicable Health Canada guidance.

Good manufacturing practices (GMP) ensure that drugs meet the quality standards appropriate to their intended use before they are sold.

COVID-19 is a new disease. A vaccine or therapy to treat or prevent this disease has not yet been developed. However, the COVID-19 pandemic has resulted in a global review of therapies that may be used to treat or prevent the disease. Canada is speeding up the importation and sale of medical devices used to diagnose, treat or prevent COVID-19.